<?xml version='1.0' encoding='utf-8'?>
<document id="28929323"><sentence text="What type and dose of antidepressants are cancer and non-cancer inpatients being prescribed: a retrospective case-control study at an Australian tertiary hospital." /><sentence text="Cancer patients are often prescribed antidepressants, but little data is available about whether the type and dose are similar to prescriptions to patients with other chronic diseases" /><sentence text=" This study compared the prescription practices of antidepressants to cancer and non-cancer inpatients at a major Australian tertiary hospital and assessed side effects and potential drug-drug interactions" /><sentence text="" /><sentence text="Inpatients diagnosed with cancer within the past 12 months and prescribed antidepressants were age and gender matched to inpatients with other chronic disease conditions" /><sentence text=" Data from 75 cancer and 75 non-cancer inpatients were extracted" /><sentence text="" /><sentence text="Antidepressants were prescribed to cancer and non-cancer patients, respectively, for the treatment of depression (n = 50 vs n = 59), other mental health problems (n = 8 vs n = 11, p &lt; 0" /><sentence text="67) or unspecified reasons (n = 17 vs n = 5, p &lt; 0" /><sentence text="02)" /><sentence text=" Mirtazapine (n = 11/75) was most commonly prescribed to cancer patients followed by duloxetine (n = 9/75)"><entity charOffset="1-12" id="DDI-PubMed.28929323.s11.e0" text="Mirtazapine" /><entity charOffset="85-95" id="DDI-PubMed.28929323.s11.e1" text="duloxetine" /><pair ddi="false" e1="DDI-PubMed.28929323.s11.e0" e2="DDI-PubMed.28929323.s11.e0" /><pair ddi="false" e1="DDI-PubMed.28929323.s11.e0" e2="DDI-PubMed.28929323.s11.e1" /></sentence><sentence text=" Desvenlafaxine (n = 15/75) was prescribed most commonly to non-cancer inpatients, followed by mirtazapine (n = 11/75)"><entity charOffset="1-15" id="DDI-PubMed.28929323.s12.e0" text="Desvenlafaxine" /><entity charOffset="95-106" id="DDI-PubMed.28929323.s12.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.28929323.s12.e0" e2="DDI-PubMed.28929323.s12.e0" /><pair ddi="false" e1="DDI-PubMed.28929323.s12.e0" e2="DDI-PubMed.28929323.s12.e1" /></sentence><sentence text=" Four cancer patients and three non-cancer patients had documented adverse side effects from antidepressants" /><sentence text=" About one-third of cancer patients (n = 23/75) and about a quarter of non-cancer patients (n = 18/75) were prescribed other medicines with the potential for drug-drug interactions with antidepressants" /><sentence text="" /><sentence text="Antidepressants were prescribed for a range of indications in all patients, but more commonly for unspecified reasons among the cancer patients" /><sentence text=" Future prospective studies that monitor antidepressant prescribing to cancer patients should ascertain details of the indication, pathways to prescription and differences in type, dose or schedule depending on prescribing medical practitioner" /><sentence text="" /></document>